to investigate the feasibility of a novel form of endocrine therapy that would exploit such dependence , we treated 8 patients with non-endocrine solid tumours with the somatostatin analogue sms 201-995 , in an effort to reduce growth hormone-stimulated igf-i production .
C0014136
endocrine
C0014132
endocrine